Premium
Early use of continuous glucose monitoring in children and adolescents after total pancreatectomy with islet autotransplantation
Author(s) -
McEachron Kendall R.,
Potlapalli Neha,
Rayannavar Arpana,
Downs Elissa M.,
Schwarzenberg Sarah J.,
Kirchner Varvara A.,
Beilman Gregory J.,
Chinnakotla Srinath,
Bellin Melena D.
Publication year - 2021
Publication title -
pediatric diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 75
eISSN - 1399-5448
pISSN - 1399-543X
DOI - 10.1111/pedi.13168
Subject(s) - medicine , autotransplantation , continuous glucose monitoring , glycemic , islet , randomized controlled trial , pancreatectomy , diabetes mellitus , insulin , emergency medicine , pediatrics , surgery , transplantation , endocrinology , pancreas
Background Children undergoing total pancreatectomy with islet autotransplantation (TPIAT) for chronic pancreatitis require intensive insulin therapy early after TPIAT with narrow glycemic targets, which can a present significant care burden. Outpatient use of continuous glucose monitoring (CGM) systems by children and caregivers early after TPIAT is inadequately studied. Methods In this open‐label study, we randomized 14 children and adolescents (mean age 15.4 years) after hospital discharge for TPIAT to Dexcom G6 CGM ( n = 7) or standard care with a glucometer ( n = 7) to assess acceptability and glycemic control with use of CGM versus usual care (glucometer). Participants in the control arm also wore a blinded CGM for 1 week. Result Children randomized to real‐time CGM had lower mean sensor glucose values compared with controls ( p = 0.002), and high overall satisfaction with CGM. Conclusions Our data indicate that CGM is a useful adjunct to diabetes management for children who have recently undergone TPIAT.